Evidence map›Paper›PMID 42161663›Full record

ReviewZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2026

[Epstein-Barr virus-positive nodal T/NK-cell lymphoma presenting with hemophagocytic lymphohistiocytosis: a case report and literature review].

J Y Qiu, Y P Liu, H L Mi, Y L Yang, F Liang, H Z Fang, X T Jia, J Y Li, Y Miao

Abstract readCase ReportsReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

J Y QiuNanjing Pukou People's Hospital, Liangjiang Hospital, Southeast University, Nanjing 211800, China.
Y P LiuDepartment of Hematology, Lymphoma Center, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
H L MiNanjing Pukou People's Hospital, Liangjiang Hospital, Southeast University, Nanjing 211800, China.
Y L YangNanjing Pukou People's Hospital, Liangjiang Hospital, Southeast University, Nanjing 211800, China.
F LiangNanjing Pukou People's Hospital, Liangjiang Hospital, Southeast University, Nanjing 211800, China.
H Z FangNanjing Pukou People's Hospital, Liangjiang Hospital, Southeast University, Nanjing 211800, China.
X T JiaNanjing Pukou People's Hospital, Liangjiang Hospital, Southeast University, Nanjing 211800, China.
J Y LiDepartment of Hematology, Lymphoma Center, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Y MiaoDepartment of Hematology, Lymphoma Center, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To enhance our understanding of Epstein-Barr virus (EBV) -positive nodal T/natural killer (NK) cell lymphoma and improve the early recognition and diagnosis of patients presenting with hemophagocytic syndrome (HLH) as the initial manifestation, this article retrospectively summarizes clinical data for a case of EBV-positive nodal T/NK cell lymphoma presenting with HLH at onset and reviews relevant literature. The patient, a 58-year-old male, presented with a "fever for 6 days" as the chief complaint, with the initial clinical manifestation being HLH. Despite active standard treatment, the patient died less than 2 months after diagnosis. EBV-positive nodal T/NK cell lymphoma is clinically rare and easily misdiagnosed. Most patients are diagnosed at an advanced stage. Furthermore, there is currently no standard treatment, leading to an extremely poor prognosis.

Indexed as

Lymphohistiocytosis, HemophagocyticLymphoma, Extranodal NK-T-CellEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHumansMaleMiddle AgedRetrospective Studies

Identifiers

PMID42161663
PMCPMC13195545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.